Novartis P/B Ratio
Novartis P/B ratio. Novartis (NOVARTIND) P/B ratio is 5.81 (High), book value per share ₹681.67 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see NOVARTIND screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NOVARTIND P/B Ratio — Valuation Insights & Book Value Analysis
Novartis price-to-book ratio interpretation, valuation status and historical context — current P/B 5.81 (High). View NOVARTIND 52-week performance for the annual high/low range and current price position.
- Stock appears overvalued with PB of 5.81, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 270.1% above historical average
- Trading at premium to sector average PB of 0.01
Novartis P/B Ratio Historical Trend
NOVARTIND annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse Novartis ownership structure to track promoter, FII and institutional holdings.
NOVARTIND Historical P/B Ratio — Book Value Per Share & Year-End Price
Novartis annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.89 | ₹681.67 | ₹1967.80 | ₹818 | Moderate |
| 2025 | 1.19 | ₹654.17 | ₹779.00 | ₹785 | Moderate |
| 2024 | 1.48 | ₹620.83 | ₹919.80 | ₹745 | Moderate |
| 2023 | 1.16 | ₹646.67 | ₹748.25 | ₹776 | Moderate |
| 2022 | 1.13 | ₹576.67 | ₹650.00 | ₹692 | Moderate |
NOVARTIND vs Healthcare Peers — P/B Ratio Comparison
Novartis P/B 5.81 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |